Emily Pond

BRAF V600E molecules were found to be homogenously distributed throughout the tumor and are associated with improved prognosis in SSMs.

The researchers evaluated the clinical characteristics of uveitis in patients with psoriatic arthritis, as well as the effect of uveitis on health-related quality of life.

Investigators report real-world evidence on the treatment of atopic dermatitis derived from the TARGET-DERM study.

To better explore the effects of medical marijuana, investigators conducted a pragmatic, single-site, single-blind randomized controlled trial in the Greater Boston area between 2017 and 2020.

A review of dermatological adverse events associated with anti-glaucoma eye drop is provided.

Investigators examined racial and ethnic representation in IBD clinical trials, assessing trends over time and offering strategies to improve recruitment and design.

Researchers conducted a survey to determine whether physicians can estimate patients’ out-of-pocket expenses, based on information about drug prices and patients’ insurance plans.

The efficacy and safety of tralokinumab plus topical corticosteroids in adult patients with inadequately controlled severe atopic dermatitis (AD) is assessed.

The safety and efficacy of upadacitinib vs dupilumab in adults with atopic dermatitis is assessed.

Investigators assessed the impact of mask wearing on perception of health during the COVID-19 pandemic.

In a systematic review, study authors assessed the effect of anakinra on mortality in patients hospitalized with COVID-19.

The American College of Rheumatology and Vasculitis Foundation released evidence-based recommendations for the management of giant cell arteritis and Takayasu arteritis.

The efficacy of 577-nm pro-yellow laser to treat or cure certain vascular skin diseases was assessed.

Study authors reported on the reactivation of herpes zoster following mRNA COVID-19 vaccination in some patients with autoimmune inflammatory rheumatic diseases.

The efficacy of recipient site preparation using dermabrasion, cryoblister, and dermaroller followed by NCES in stable vitiligo were compared.

The 6-month risk for conjunctivitis in patients with atopic dermatitis treated with dupilumab was evaluated.

Researchers analyzed real-world evidence on the safety and efficacy of dupilumab to treat atopic dermatitis.

Evidence-based guidelines address supportive care treatment options for adult patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.